Stock image by PDPics from PixabayA Flinders University study shows that bowel cancer survivors face an elevated risk of ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

If you or someone you know has received a prostate cancer diagnosis, here's where to start, what to ask and how to plan ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

A large Department of Veterans Affairs cohort study revealed key racial differences in genomic alterations among men with metastatic prostate cancer.

A new population-level study from Uppsala University has found that most men treated for non-metastatic prostate cancer according to current clinical guidelines have a favorable long-term prognosis.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...

J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic prostate cancer.